Mice receiving pacRNAClv showed the most appreciable down-regulation of Bcl-2 protein expression (62% knockdown) following treatment, as evidenced by Western blotting of homogenized tumor tissues (Fig. 5G). This evidence concerns the gene BCL2 and neoplasm.